Skip to content

Clinical trials

Phase 4 Schizophrenia trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Country / region: Spain Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20053
20062
20071
20082
20102
20111
20142
20152
20161
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status5
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fundación Marques de Valdecilla6
Fundació Sant Joan de Déu3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
AstraZeneca1
Bristol-Myers Squibb1
Consorci Hospitalari de Vic1
Dr. Inge Winter1
Eli Lilly and Company1
Ferrer Internacional S.A.1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia20
Psychotic Disorders10
Bipolar Disorder2
Mental Disorders1
Metabolic Syndrome1
Mood Disorders1
Personality Disorders1
Psychomotor Agitation1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.